|Bid||1.00 x 1200|
|Ask||1.02 x 46000|
|Day's Range||0.98 - 1.06|
|52 Week Range||0.98 - 2.55|
|Beta (3Y Monthly)||1.79|
|PE Ratio (TTM)||1.51|
|Earnings Date||Sep 20, 2017 - Sep 25, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.31|
The rating for this CTL lease transaction Cl. A-2 was downgraded primarily due to downgrade Rite Aid Corporation senior unsecured rating to Caa1/Caa2. This concludes a review which was initiated on August 13, 2018 due to Rite Aid Corporation senior unsecured rating being placed on review for possible downgrade. On October 15, 2018 Rite Aid Corporation senior unsecured rating was downgraded to Caa1/Caa2 from B3/Caa1 with negative outlook.
As the annual Medicare Part D election period gets underway, from now through Dec. 7, 2018, Medicare-eligible customers can visit Rite Aid pharmacies nationwide to take advantage of free resources that help them select the right prescription drug plan or update existing coverage for 2019.
As Snap (NYSE:SNAP) continues to struggle against its larger social media peers, Snap stock looks uglier all the time. The parent company of Snapchat has attracted a large user base and a following among the young. Some critics argue that it does not matter that Facebook (NASDAQ:FB) copies its features.
Moody's Investors Service ("Moody's") today downgraded Rite Aid Corporation's Corporate Family Rating and probability of default rating to B3 and B3-PD from B2 and B2-PD respectively. Moody's ...
As we’ve already seen in this series, Walgreens Boots Alliance (WBA) posted better-than-expected fourth quarter of fiscal 2018 earnings yesterday but missed the top-line projections.
Moody's Investors Service, ("Moody's") has affirmed the rating on three classes in ML-CFC Commercial Mortgage Trust 2007-5, Commercial Mortgage Pass-Through Certificates, 2007-5 as follows: Cl. ...
As we’ve already seen in this series, Walgreens Boots Alliance’s (WBA) fourth quarter of fiscal 2018 sales increased 11% YoY (year-over-year) to $33.4 billion. As in the previous quarters, growth was driven by a strong performance of its Retail Pharmacy USA division.
Walgreens Boots Alliance (WBA) reported its fourth quarter of fiscal 2018 results yesterday. Organic sales rose 3.2%. Behind the miss was a fall in sales of personal care products and over-the-counter drugs.
Shares of Rite Aid were trailing and closed down over 6% despite the company not having any news. Walgreens Boots Alliance, Inc. shares were down nearly 2% on Thursday on about 14.5 million shares traded. Walgreens reported adjusted earnings per share (EPS) of $1.48, beating street’s estimate of $1.45.
was the biggest gainer on the Dow Jones Industrial Average Thursday, Oct. 11, after it reported earnings for the first time as an index component. Walgreens replaced General Electric Co. Pharmacy chain Walgreens edged up 1.4% on Thursday, while the Dow continued falling falling a sharp selloff during the previous session.
Brick-and-mortar drug retailers have been hit as consumers are increasingly buying over-the-counter treatments from online retailers such as Amazon.com. "We are moderately encouraged that Walgreens is starting to make long overdue changes," said Neil Saunders, managing director of GlobalData Retail.
Walgreens Boots Alliance Inc came up short of analysts' estimates for quarterly revenue on Thursday, as sales of personal care products and over-the-counter drugs fell both in its home market and at its UK-based Boots chain. Brick-and-mortar drug retailers have been hit as consumers are increasingly buying over-the-counter treatments from online retailers such as Amazon.com.
Walgreens Boots Alliance Inc reported an 88.5 percent rise in quarterly profit on Thursday, as more people brought prescription medicines from its pharmacies and it benefited from its acquisition of Rite ...
RBC Capital Markets raised the price target for drugstore chain Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8. Analyst George Hill maintained an “outperform” recommendation for the company and said Walgreens was one of the best-positioned companies in the retail pharmacy space. Although Hill is still concerned about Walgreens’s pricing in the United States, he expects some improvement in the Medicare Part D preferred pharmacy network business next year.
Walgreens stock has witnessed a high level of volatility over the past year. Its price has moved between $59.07 and $80.68 over the last 52 weeks.
The drugstore operator's stock has closed at the exact same price for the last four consecutive days. Let's fix the clock broken at a $1.15 close.
After being battered in the stock market during the first six months of 2018, Walgreens Boots Alliance (WBA) has finally bounced back. Shares of WBA were down ~18% as of June 28, when the company reported its fiscal 2018 third-quarter results. It was instead the result of fears about Amazon expanding its footprint in the pharmacy retail space.
Wall Street expects a 10.7% YoY (year-over-year) jump in Walgreens Boots Alliance’s (WBA) EPS to $1.45 during the fourth quarter of fiscal 2018. The pharmacy giant hasn’t missed analysts’ earnings expectations for the last 16 consecutive quarters.
Albertsons sells nearly a quarter of all of the liquor in Washington state. Here's a breakdown of the cities with the highest sales and the stores that sell the most.
‘SUPPORT for Patients and Communities Act’ expands eligibility for Medicare Part D seniors to receive Medication Therapy Management counseling services from pharmacists